{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T16:52:24Z","timestamp":1794243144234,"version":"4.9.0"},"reference-count":36,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T00:00:00Z","timestamp":1759795200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Central precocious puberty (CPP) in girls is characterized by premature activation of the hypothalamic-pituitary-gonadal axis, often leading to early epiphyseal closure and compromised adult height. While gonadotropin-releasing hormone analogues (GnRHa) are the standard therapy to suppress puberty and preserve height potential, the benefit of adding growth hormone (GH) to improve height outcomes remains unclear. This work aims to evaluate the efficacy of combined GnRHa and GH therapy compared to GnRHa monotherapy in improving growth outcomes in girls with CPP.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A systematic search of PubMed, Embase, Web of Science, and Cochrane Library was conducted up to May 2025. Eligible studies comparing GnRHa + GH combination therapy to GnRHa monotherapy in girls with CPP were included. Primary outcomes included final height and final height minus target height (FH\u2013TH). Secondary outcomes included predicted adult height (PAH), height gain, height change during treatment, growth velocity, and bone maturation (\u0394BA\/\u0394CA). Pooled weighted mean differences (WMDs) and 95% confidence intervals (CIs) were calculated using fixed- or random-effects models based on heterogeneity. Subgroup analyses were conducted by study design.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Nine studies were included. Combination therapy significantly improved FH\u2013TH (WMD = 1.01 cm, 95% CI: 0.28 to 1.73; P = 0.006), PAH (WMD = 4.27 cm, 95% CI: 3.47 to 5.08; P &amp;lt; 0.0001), height gain (WMD = 3.45 cm, 95% CI: 1.73 to 5.17; P &amp;lt; 0.0001), height change during treatment (WMD = 3.31 cm, 95% CI: 1.76 to 4.86; P &amp;lt; 0.0001), and growth velocity (WMD = 1.40 cm\/year, 95% CI: 0.90 to 1.91; P &amp;lt; 0.0001), with no significant effect on bone maturation (\u0394BA\/\u0394CA) (WMD = 0.01, 95% CI: \u20130.05 to 0.07; P = 0.77). No significant improvement in final height was observed (WMD = 0.14 cm, 95% CI: \u20131.66 to 1.94; P = 0.88).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>GH supplementation during GnRHa treatment in girls with CPP enhances short-term growth outcomes without accelerating bone age but does not consistently improve final adult height. Combination therapy may be considered for selected patients with poor growth prognosis; however, further high-quality randomized trials are needed to refine patient selection and optimize treatment strategies.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2025.1662808","type":"journal-article","created":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T04:14:06Z","timestamp":1759810446000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Efficacy of combined gonadotropin-releasing hormone analogue and growth hormone therapy in girls with central precocious puberty: a systematic review and meta-analysis"],"prefix":"10.3389","volume":"16","author":[{"given":"Sufeng","family":"Jin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhouyue","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haitao","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,10,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1007\/s40272-015-0130-8","article-title":"Central precocious puberty: update on diagnosis and treatment","volume":"17","author":"Chen","year":"2015","journal-title":"Paediatr Drugs"},{"key":"B2","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.3389\/fendo.2022.1008474","article-title":"Final adult height in children with central precocious puberty \u2013 a retrospective study","volume":"13","author":"Knific","year":"2022","journal-title":"Front Endocrinol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-08-0814","article-title":"The use of GnRH agonists in precocious puberty","author":"Mul","year":"2008","journal-title":"Eur J Endocrinol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"92","DOI":"10.21037\/tp-24-439","article-title":"Efficacy and safety of different doses of gonadotropin-releasing hormone analogues in the treatment of precocious puberty in children: a systematic review and meta-analysis","volume":"14","author":"Jin","year":"2025","journal-title":"Transl Pediatr"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1159\/000535132","article-title":"The effect of gnRHa treatment on body mass index in central precocious puberty: A systematic review and meta-analysis","volume":"97","author":"Hou","year":"2024","journal-title":"Horm Res Paediatr"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2002-021154","article-title":"Bone mass at final height in precocious puberty after gonadotropin-releasing hormone agonist with and without calcium supplementation","volume":"88","author":"Antoniazzi","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1498726","article-title":"Adult height in girls with idiopathic central precocious puberty treated with triptorelin","volume":"15","author":"Corripio","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B8","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1210\/er.2015-1026","article-title":"Growth and the growth hormone-insulin like growth factor 1 axis in children with chronic inflammation: current evidence, gaps in knowledge, and future directions","volume":"37","author":"Wong","year":"2016","journal-title":"Endocrine Rev"},{"key":"B9","doi-asserted-by":"publisher","first-page":"29","DOI":"10.23750\/abm.v91i1.9182","article-title":"Effect of growth hormone treatment on children with idiopathic short stature (ISS), idiopathic growth hormone deficiency (IGHD), small for gestational age (SGA) and Turner syndrome (TS) in a tertiary care center","volume":"91","author":"Al Shaikh","year":"2020","journal-title":"Acta BioMed"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1159\/000499929","article-title":"The effect of gonadotropin-releasing hormone analogue on final adult height in children with idiopathic short stature","volume":"28","author":"Khawaja","year":"2019","journal-title":"Med Princ Pract"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1297\/cpe.24.175","article-title":"Age at menarche and near final height after treatment with gonadotropin-releasing hormone agonist alone or combined with growth hormone in Korean girls with central precocious puberty","volume":"24","author":"Gyon","year":"2015","journal-title":"Clin Pediatr Endocrinol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1515\/jpem.2000.13.s1.811","article-title":"Combined therapy with GnRH analog plus growth hormone in central precocious puberty","author":"Pucarelli","year":"2000","journal-title":"J Pediatr Endocrinol Metab"},{"key":"B13","doi-asserted-by":"publisher","first-page":"24259","DOI":"10.1038\/srep24259","article-title":"The efficacy of gnRHa alone or in combination with rhGH for the treatment of chinese children with central precocious puberty","volume":"6","author":"Wang","year":"2016","journal-title":"Sci Rep"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2022.37.e90","article-title":"Growth responses during 3 years of growth hormone treatment in children and adolescents with growth hormone deficiency: comparison between idiopathic, organic and isolated growth hormone deficiency, and multiple pituitary hormone deficiency","volume":"37","author":"Lim","year":"2022","journal-title":"J Korean Med Sci"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgab080","article-title":"Long-term safety of growth hormone treatment in childhood: two large observational studies: nordiNet IOS and ANSWER","volume":"106","author":"S\u00e4vendahl","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-2881","article-title":"Jauregi J et\u00a0al: Growth Hormone Therapy for Children and Adolescents with Prader-Willi Syndrome Is Associated with Improved Body Composition and Metabolic Status in Adulthood","volume":"98","author":"Coupaye","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1038\/s41598-023-28602-3","article-title":"Effect of gonadotropin-releasing hormone agonist monotherapy and combination therapy with growth hormone on final adult height in girls with central precocious puberty","volume":"13","author":"Cho","year":"2023","journal-title":"Sci Rep"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.84.2.5431","article-title":"Adult height in girls with central precocious puberty treated with gonadotropin-releasing hormone analogues and growth hormone","volume":"84","author":"Pasquino","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.6065\/apem.2019.24.2.116","article-title":"Comparing adult height gain and menarcheal age between girls with central precocious puberty treated with gonadotropin-releasing hormone agonist alone and those treated with combined growth hormone therapy","volume":"24","author":"Kim","year":"2019","journal-title":"Ann Pediatr Endocrinol Metab"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2005.02323.x","article-title":"Final height after treatment of early puberty in short adopted girls with gonadotrophin releasing hormone agonist with or without growth hormone","volume":"63","author":"Mul","year":"2005","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.1085385","article-title":"Gonadotropin-releasing hormone analogue and recombinant human growth hormone treatment for idiopathic central precocious puberty in girls","volume":"13","author":"Shi","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B22","first-page":"25","article-title":"Effects of gonadotropin releasing hormone analog and growth hormone on height in girls with idiopathic central precocious puberty","volume":"16","author":"Wang","year":"2014","journal-title":"Zhongguo Dang Dai Er Ke Za Zhi"},{"key":"B23","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/S0849-5831(97)80026-2","article-title":"Precocious puberty: changing trends in diagnosis and treatment","volume":"19","author":"Barnes","year":"1997","journal-title":"J SOGC"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1309904","article-title":"Puberty suppression in adolescents with gender dysphoria: an emerging issue with multiple implications","volume":"15","author":"Betsi","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B25","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.3389\/fendo.2023.1113750","article-title":"Gies I et\u00a0al: Efficacy and safety of a 4-year combination therapy of growth hormone and gonadotropin-releasing hormone analogue in pubertal girls with short predicted adult height","volume":"14","author":"Dotremont","year":"2023","journal-title":"Front Endocrinol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2019-00233","article-title":"The beneficial effect of combined GH\/gnRHa therapy in increasing adult height outcome in children with ISS","volume":"104","author":"Lazar","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"B27","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1186\/s12887-025-05703-8","article-title":"Combination therapy of GnRHa, RhGH and anastrozole to improve final adult height deficit in CAH children with CPP","volume":"25","author":"Liu","year":"2025","journal-title":"BMC Pediatr"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1159\/000501336","article-title":"Use of gonadotropin-releasing hormone analogs in children: update by an international consortium","volume":"91","author":"Bangalore Krishna","year":"2019","journal-title":"Hormone Res Paediatrics"},{"key":"B29","doi-asserted-by":"publisher","first-page":"33","DOI":"10.4274\/jcrpe.2017.S004","article-title":"A critical appraisal of the effect of gonadotropin-releasing hormon analog treatment on adult height of girls with central precocious puberty","volume":"9","author":"Bereket","year":"2017","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.84.10.6032","article-title":"Lack of effect of gnRH agonists on final height in girls with advanced puberty: A randomized long-term pilot study","volume":"84","author":"Bouvattier","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"B31","doi-asserted-by":"publisher","first-page":"bvab036","DOI":"10.1210\/jendso\/bvab036","article-title":"Long-term GH therapy does not advance skeletal maturation in children and adolescents","volume":"5","author":"Nwosu","year":"2021","journal-title":"J Endocr Soc"},{"key":"B32","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1687-9856-2014-15","article-title":"Growth hormone significantly increases the adult height of children with idiopathic short stature: comparison of subgroups and benefit","volume":"2014","author":"Sotos","year":"2014","journal-title":"Int J Pediatr Endocrinol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.6065\/apem.2014.19.4.214","article-title":"Adult height in girls with central precocious puberty treated with gonadotropin-releasing hormone agonist with or without growth hormone","volume":"19","author":"Jung","year":"2014","journal-title":"Ann Pediatr Endocrinol Metab"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-016-0486-9","article-title":"Effects and safety of combination therapy with gonadotropin-releasing hormone analogue and growth hormone in girls with idiopathic central precocious puberty: a meta-analysis","volume":"39","author":"Liu","year":"2016","journal-title":"J Endocrinol Invest"},{"key":"B35","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.3389\/fendo.2021.812196","article-title":"Should skeletal maturation be manipulated for extra height gain","volume":"12","author":"Wit","year":"2021","journal-title":"Front Endocrinol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1136\/adc.87.3.215","article-title":"High dose growth hormone treatment induces acceleration of skeletal maturation and an earlier onset of puberty in children with idiopathic short stature","volume":"87","author":"Kamp","year":"2002","journal-title":"Arch Dis Child"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1662808\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T04:14:07Z","timestamp":1759810447000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1662808\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,7]]},"references-count":36,"alternative-id":["10.3389\/fendo.2025.1662808"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2025.1662808","relation":{"has-part":[{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fendo.2025.1662808.s001","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fendo.2025.1662808.s002","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fendo.2025.1662808.s003","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fendo.2025.1662808.s004","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fendo.2025.1662808.s005","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fendo.2025.1662808.s006","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fendo.2025.1662808.s007","asserted-by":"subject"}]},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,7]]},"article-number":"1662808"}}